Do lasers or topicals really work for nonmelanoma skin cancers?

Novel strategies are urgently needed to address the millions of nonmelanoma skin cancers treated in the United States annually. The need is greatest for those patients who are poor surgical candidates or those prone to numerous nonmelanoma skin cancers and therefore at risk for marked disfigurement. Traditional treatment strategies include electrosurgery with curettage, radiation therapy, cryotherapy, excision, and Mohs micrographic surgery. Alternatives to traditional treatment, including topical medications and light or laser therapies, are becoming popular; however, there are various degrees of efficacy among these alternative tactics. These alternatives include topical retinoids, peels, 5-fluorouracil, imiquimod, photodynamic therapy, and lasers. The purpose of this paper is to review the available data regarding these alternative strategies and permit the reader to have a sense of which therapies are reasonable options for care.

[1]  K. Peris,et al.  Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. , 2007, European journal of dermatology : EJD.

[2]  H. Soyer,et al.  Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.

[3]  C. Whitehurst,et al.  Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid‐based photodynamic therapy , 2000, The British journal of dermatology.

[4]  David A. Lee,et al.  Nonmelanoma skin cancer. , 2009, Facial plastic surgery clinics of North America.

[5]  H. S. de Bruijn,et al.  PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination. , 2002, The Journal of investigative dermatology.

[6]  S. Chimenti,et al.  Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. , 1999, The New England journal of medicine.

[7]  S. Kossard,et al.  Imiquimod 5% cream in the treatment of Bowen's disease. , 2001, Journal of the American Academy of Dermatology.

[8]  K. Nouri,et al.  Ultrapulse CO2 Used for the Successful Treatment of Basal Cell Carcinomas Found in Patients with Basal Cell Nevus Syndrome , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[9]  A. Finlay,et al.  Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. , 2006, Journal of the American Academy of Dermatology.

[10]  J. Spencer Pilot Study of Imiquimod 5% Cream as Adjunctive Therapy to Curettage and Electrodesiccation for Nodular Basal Cell Carcinoma , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  J. Bonnetblanc,et al.  [Photodynamic therapy for the treatment of extramammary Paget's disease]. , 2012, Annales de dermatologie et de venereologie.

[12]  C. Morton,et al.  Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.

[13]  P. Nelemans,et al.  Mohs' micrographic surgery for treatment of basal cell carcinoma of the face——results of a retrospective study and review of the literature , 2004, The British journal of dermatology.

[14]  F. Moloney,et al.  Randomized, double‐blind, prospective study to compare topical 5‐aminolaevulinic acid methylester with topical 5‐aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis , 2007, The British journal of dermatology.

[15]  N. Horlock,et al.  Can the carbon dioxide laser completely ablate basal cell carcinomas? A histological study. , 2000, British journal of plastic surgery.

[16]  K. Giercksky,et al.  A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. , 2001, The British journal of dermatology.

[17]  Z. Tannous,et al.  The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas , 2009, Lasers in surgery and medicine.

[18]  J. Huber,et al.  Topical Imiquimod Treatment for Nodular Basal Cell Carcinomas: An Open‐Label Series , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[19]  S. Kusamura,et al.  Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study. , 2006, Gynecologic oncology.

[20]  Rik Roelandts,et al.  Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. , 2008, European journal of dermatology : EJD.

[21]  Menno A de Rie,et al.  Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. , 2007, Archives of dermatology.

[22]  G. Kricorian,et al.  5% 5‐Fluorouracil Cream for the Treatment of Small Superficial Basal Cell Carcinoma: Efficacy, Tolerability, Cosmetic Outcome, and Patient Satisfaction , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[23]  C. Morton,et al.  Randomized comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease , 2003, The British journal of dermatology.

[24]  B. Gilchrest,et al.  Photodynamic Therapy for Patients with Basal Cell Nevus Syndrome , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[25]  S. Ibbotson,et al.  Clinical and research applications of photodynamic therapy in dermatology: Experience of the scottish PDT centre , 2006, Lasers in surgery and medicine.

[26]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[27]  J. Taylor,et al.  A Pilot Study to Evaluate the Treatment of Basal Cell Carcinoma with 5‐Fluorouracil Using Phosphatidyl Choline as a Transepidermal Carrier , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[28]  S. Shumack,et al.  Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. , 2002, Archives of dermatology.

[29]  J. Moan,et al.  Photodynamic Therapy of Superficial Basal Cell Carcinoma with 5-Aminolevulinic Acid with Dimethylsulfoxide and Ethylendiaminetetraacetic Acid: A Comparison of Two Light Sources , 2000, Photochemistry and photobiology.

[30]  G. P. Lozzi,et al.  Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma. , 2006, Journal of the American Academy of Dermatology.

[31]  B. Thiers 5% 5-Fluorouracil Cream for the Treatment of Small Superficial Basal Cell Carcinoma: Efficacy, Tolerability, Cosmetic Outcome, and Patient Satisfaction , 2008 .

[32]  A. Oseroff,et al.  Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies , 2009, International journal of dermatology.

[33]  Ann-Marie Wennberg,et al.  Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. , 2007, Journal of the American Academy of Dermatology.

[34]  C. A. Thissen,et al.  Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. , 2006, Journal of drugs in dermatology : JDD.

[35]  T. Viset,et al.  Photodynamic therapy with 5‐aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6‐year clinical and histological follow‐up , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[36]  J. Hochman,et al.  Topical Treatment of Bowen's Disease with 5-Fluorouracil , 2003 .

[37]  C. Whitehurst,et al.  Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.

[38]  N. Bendsoe,et al.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial , 2001, The British journal of dermatology.

[39]  R. Marks,et al.  Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. , 2001, Journal of the American Academy of Dermatology.

[40]  K. Welsh,et al.  Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate , 2004, Transplantation.

[41]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[42]  A. Anstey,et al.  Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large‐field incoherent light source , 2001, The British journal of dermatology.

[43]  M. Thissen,et al.  SHORT COMMUNICATIONPhotodynamic therapy with delta‐aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique , 2000, The British journal of dermatology.

[44]  David J Goldberg,et al.  A Review of Laser and Photodynamic Therapy for the Treatment of Nonmelanoma Skin Cancer , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[45]  K. Beutner,et al.  Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. , 1999, Journal of the American Academy of Dermatology.

[46]  T. Humphreys,et al.  Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. , 1998, Archives of dermatology.

[47]  E. D. Smith,et al.  Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[48]  Marek Vlk,et al.  Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma , 2008, Lasers in surgery and medicine.

[49]  D. Selva,et al.  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. , 2005, Journal of the American Academy of Dermatology.

[50]  Brett M. Coldiron,et al.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.

[51]  G. Stables,et al.  Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy. , 2005, Journal of the American Academy of Dermatology.

[52]  I. Whitaker,et al.  Combined CO(2) laser with photodynamic therapy for the treatment of nodular basal cell carcinomas. , 2007, Annals of Plastic Surgery.

[53]  L. Schouten,et al.  A systematic review of treatment modalities for primary basal cell carcinomas. , 1999, Archives of dermatology.

[54]  P. Wolf,et al.  Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. , 2006, Archives of dermatology.

[55]  J. L. Smith,et al.  Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006 , 2011 .

[56]  F. Bardazzi,et al.  A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ. , 2005, Journal of the American Academy of Dermatology.

[57]  L. Golitz,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. , 2004, Journal of the American Academy of Dermatology.

[58]  J. Moan,et al.  Photodynamic Therapy of Superficial Basal Cell Carcinoma with 5‐Aminolevulinic Acid with Dimethylsulfoxide and Ethylendiaminetetraacetic Acid: A Comparison of Two Light Sources , 2000 .

[59]  R. Sengelmann,et al.  Nonsurgical Treatment Modalities for Primary Cutaneous Malignancies , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[60]  Timothy A. Dall,et al.  The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. , 2006, Journal of the American Academy of Dermatology.

[61]  J. D. de Fijter,et al.  Trends of skin diseases in organ‐transplant recipients transplanted between 1966 and 2006: a cohort study with follow‐up between 1994 and 2006 , 2010, The British journal of dermatology.

[62]  S. Iyer,et al.  Treatment of Basal Cell Carcinoma with the Pulsed Carbon Dioxide Laser: A Retrospective Analysis , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[63]  C. Ferrándiz,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle‐controlled phase III study in Europe , 2005, The British journal of dermatology.

[64]  P. Steijlen,et al.  Fractionated 5‐aminolaevulinic acid–photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial , 2008, The British journal of dermatology.

[65]  M. Murison,et al.  Combined CO2 Laser With Photodynamic Therapy for the Treatment of Nodular Basal Cell Carcinomas , 2007 .

[66]  B. Katz,et al.  Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT. , 2007, Journal of Drugs in Dermatology.

[67]  C. Garbe,et al.  A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. , 2007, Journal of the American Academy of Dermatology.

[68]  K. Gross,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. , 2002, Journal of the American Academy of Dermatology.

[69]  R. Geronemus,et al.  What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream. , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[70]  H. Gollnick,et al.  Photodynamic Therapy in Dermatology , 2012 .

[71]  L. Izikson,et al.  Noninvasive Extramammary Paget's Disease Treated with Photodynamic Therapy: Case Series from the Roswell Park Cancer Institute , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[72]  T. H. Nguyen,et al.  Nonmelanoma skin cancer , 2002, Current treatment options in oncology.

[73]  D. Nicol,et al.  Non-melanoma skin cancer risk in the Queensland renal transplant population. , 2002 .

[74]  R. Grouls,et al.  Development of a Stable Solution of 5-Aminolaevulinic Acid for Intracutaneous Injection in Photodynamic Therapy , 2002, Lasers in Medical Science.

[75]  D. Nicol,et al.  Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[76]  C. Whitehurst,et al.  Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy , 2000, The British journal of dermatology.

[77]  L. Lowe,et al.  Concomitant use of a high-energy pulsed CO2 laser and a long-pulsed (810 nm) diode laser for squamous cell carcinoma in situ. , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].